Research Projects & Grants

  • Emergency use of Cisapride for infant feeding intolerance., Role: PI, Status: Completed

Federal

  • Pain and hypoxia in premature neonates, Role: Investigator, National Institutes of Health/DHHS, (06/2024 - 06/2025) Status: Approved
  • Systemic Hypotension following pediatric surgical procedures including patent ductus arteriosus ligation: the role of adrenal immaturity, Role: Investigator, National Heart, Lung, and Blood Institute/NIH/DHHS, (02/2012 - 02/2013) Status: Completed
  • Pain and Hypoxia in Premature Neonates, Role: Consultant, National Institute of Nursing Research/NIH/DHHS, (07/2009 - 04/2014) Status: Closed
  • Pharmacokinetics of L-arginine in premature infants, Role: Co-investigator, National Medical Technology Testbed, Inc., (02/2009 - 03/2011) Status: Closed
  • Procedural pain and hypoxia in preterm infants (R21), Role: Co-investigator, National Institutes of Health/DHHS, (07/2007 - 05/2008) Status: Closed

For Profit Organization

  • An open label, multicenter, phase 2, pilot evaluation of surfaxin (lucinactant) delivered as an aerosol via nasal continuous positive airway pressure (NCPAP) in the prevention of respiratory distress syndrome in premature infants, Role: Investigator, Discovery Laboratories, Inc., (01/2006 - 01/2007) Status: Completed
  • KL4-BPD-01 A randomized, double-blind, placebo-controlled trials to assess the safety and efficacy of surfaxin® (lucinactant), in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia. IND # 40,287, Role: Investigator, Discovery Laboratories, Inc., (08/2005 - 08/2006) Status: Completed
  • A phase III randomized, double-blind, multi-center clinical trial comparing the safety and efficacy of Veronate versus placebo for the prevention of nosocomial staphylococcal sepsis in premature infants (birth weight 500-1250gm), Role: Investigator, Inhibitex, Inc., (07/2005 - 07/2006) Status: Completed
  • A pivotal phase III study of MEDI-493, a humanized respiratory syncytial virus monoclonal antibody, for the prophylaxis of severe RSV disease in premature infants and infants with bronchopulmonary dysplasia, Role: Investigator, MedImmune, Inc., (10/1996 - 10/1997) Status: Completed
  • Multicenter phase II study to assess the safety and preliminary efficacy of multiple doses of INH-A21, a donor selected human Staphylococcal Immune Globulin, in very low birth weight infants, Role: Investigator, Inhibitex, Inc., Status: Completed

Internal

  • Non-pharmacological interventions for procedural pain in premature neonates, Role: Investigator, LLU Basic Science, (04/2025 - 04/2026) Status: Approved
  • Comparison of standard educational neonatal resusitation program and use of etimulation educational program combined with neonatal resuscitation program: which method produces better results?, Role: Investigator, LLU School of Nursing, (09/2008) Status: Completed
  • Continous glucose measurement using the GlucoWatch G2 biographer in infants of diabetic mothers, Role: Investigator, LLU Dept. of Pediatrics, (10/2005 - 10/2006) Status: Completed
  • Supporting Parents of Premature Infants in the NICU, Role: PI, LLU Dept. of Pediatrics, (08/1995 - 08/1996) Status: Completed

Non-Profit Organization

  • A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of Necrotizing Enterocolitis - The connection study, Role: Investigator, Infant Bacterial Therapeutics AB, (04/2024 - 10/2024) Status: Completed
  • Postnatal Growth and Retinopathy of Prematurity Model Development Study (G-ROP-1), Role: Research Assistant, Children's Hospital Philadelphia, (09/2012 - 03/2019) Status: Closed